Enovachem Hit With FDA Warning

Drug Industry Daily
A A
The FDA issued a warning letter to Enovachem for serious deviations from current good manufacturing practices for its APIs, in a follow-up to a Sept. 25-27, 2018 inspection of the firm’s Torrence, California manufacturing facility.

To View This Article:

Login

Subscribe To Drug Industry Daily